AdventHealthMD
A recent study, called FLOW, showed Ozempic had dramatic results in slowing chronic kidney disease progression in participants with Type 2 diabetes.
The AdventHealth Heart, Lung and Vascular Institute recently designed a new program, called the Comprehensive Atrial Fibrillation to help treat patients with long-standing Atrial Fibrillation (AFib)...
AdventHealth Neuroscience Institute’s (NSI) Movement Disorder Program recently began offering bilateral (second-side) treatment of essential tremor (ET) with MR-guided Focused Ultrasound (MRgFUS)...
In this episode of the Inspiring Wholeness podcast, AdventHealth's Dr. Rajan Wadhawan and Heart of Florida United Way CEO Jeff Hayward discuss Central Florida’s youth in crisis and educating them on...
In episode 2 of the Inspiring Wholeness podcast, AdventHealth Florida CEO Randy Haffner and CrossMarc Services President John Crossman tackle how to avoid mission drift.
Steven R. Smith, MD, AdventHealth’s chief scientific officer discussed AdventHealth Translational Research Institute’s decade of discovery in Central Florida on a recent webinar with the Florida...
Our website uses cookies. Please review our privacy policy to find out more about the cookies we use. Browsing our website means you accept these terms.